Lung Transplant Team

Co-morbidities in advanced pulmonary disease, Collaborative investigation in immune tolerance, Idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis, Lung volume reduction for emphysema, Novel immunosuppressive regimens and antimicrobial therapies in lung transplantation, Outcomes of patients with advanced lung disease before and after transplantation, Patient selection and outcomes on the waiting list for lung transplantation, Post-transplant complications, Predictors and diagnosis of acute and chronic lung rejection, Pulmonary embolism and thrombolytic therapy, Studies of genetic testing for diagnosis of organ rejection